mental health

News

Otsuka funds prescription therapy app for depression

Otsuka is once again betting on digital as a new avenue for depression treatment by collaborating with Click Therapeutics to develop and commercialise a ‘prescriptio

Views & Analysis

Digital health round-up: Otsuka doubles down on digital ment...

Otsuka seems to think it’s onto something by using digital tech to aid treatment of mental health disorders: in November 2017 its Abilify MyCite, a combination of the company’s antipsychoti

News

Healios begins trials of mental health app for schoolchildre...

Digital health firm Healios is beginning clinical trials of ThinkNinja, an app designed to help children with mental health problems.

News

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

Magic mushroom drug could be depression breakthrough, says F...

The liberty cap mushroom, notoriously used illegally as a psychoactive drug, could be the inspiration for a new therapy for depression according to the US drug regulator.

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J preps for FDA panel grilling over depression drug

Johnson & Johnson is “confident” about regulatory reviews of its depression drug esketamine ahead of a likely grilling by FDA experts – even though two of the five trials it is relying

News